121 related articles for article (PubMed ID: 37105709)
1. Thymoquinone inhibits lung cancer stem cell properties via triggering YAP degradation.
Zhang Y; Liu X; Dang W; Liu L
Carcinogenesis; 2023 Aug; 44(5):426-435. PubMed ID: 37105709
[TBL] [Abstract][Full Text] [Related]
2. Mutated p53 Promotes the Symmetric Self-Renewal of Cisplatin-Resistant Lung Cancer Stem-Like Cells and Inhibits the Recruitment of Macrophages.
Xu Y; Xu Z; Li Q; Guo L; Wang Y; Zhou J; Wang G; Liu Y
J Immunol Res; 2019; 2019():7478538. PubMed ID: 31781681
[TBL] [Abstract][Full Text] [Related]
3. Expansion of cancer stem cell pool initiates lung cancer recurrence before angiogenesis.
Li L; Li JC; Yang H; Zhang X; Liu LL; Li Y; Zeng TT; Zhu YH; Li XD; Li Y; Xie D; Fu L; Guan XY
Proc Natl Acad Sci U S A; 2018 Sep; 115(38):E8948-E8957. PubMed ID: 30158168
[TBL] [Abstract][Full Text] [Related]
4. Thymoquinone inhibits proliferation and invasion of human nonsmall-cell lung cancer cells via ERK pathway.
Yang J; Kuang XR; Lv PT; Yan XX
Tumour Biol; 2015 Jan; 36(1):259-69. PubMed ID: 25238880
[TBL] [Abstract][Full Text] [Related]
5. 8-bromo-7-methoxychrysin inhibits properties of liver cancer stem cells via downregulation of β-catenin.
Quan MF; Xiao LH; Liu ZH; Guo H; Ren KQ; Liu F; Cao JG; Deng XY
World J Gastroenterol; 2013; 19(43):7680-95. PubMed ID: 24431896
[TBL] [Abstract][Full Text] [Related]
6. Thymoquinone inhibited vasculogenic capacity and promoted mesenchymal-epithelial transition of human breast cancer stem cells.
Haiaty S; Rashidi MR; Akbarzadeh M; Bazmani A; Mostafazadeh M; Nikanfar S; Zibaei Z; Rahbarghazi R; Nouri M
BMC Complement Med Ther; 2021 Mar; 21(1):83. PubMed ID: 33663486
[TBL] [Abstract][Full Text] [Related]
7. CD44 is functionally crucial for driving lung cancer stem cells metastasis through Wnt/β-catenin-FoxM1-Twist signaling.
Su J; Wu S; Wu H; Li L; Guo T
Mol Carcinog; 2016 Dec; 55(12):1962-1973. PubMed ID: 26621583
[TBL] [Abstract][Full Text] [Related]
8. [Research Progress in the Therapeutic Strategy Based on Targeting at
Lung Cancer Stem Cell].
Lai H; Lin F; Chen N; Wen S; Hu X; Liu L
Zhongguo Fei Ai Za Zhi; 2018 Jan; 21(1):57-62. PubMed ID: 29357974
[TBL] [Abstract][Full Text] [Related]
9. Human non-small cell lung cancer expresses putative cancer stem cell markers and exhibits the transcriptomic profile of multipotent cells.
Zakaria N; Yusoff NM; Zakaria Z; Lim MN; Baharuddin PJ; Fakiruddin KS; Yahaya B
BMC Cancer; 2015 Feb; 15():84. PubMed ID: 25881239
[TBL] [Abstract][Full Text] [Related]
10. Notch and Wnt/β-catenin signaling pathway play important roles in activating liver cancer stem cells.
Wang R; Sun Q; Wang P; Liu M; Xiong S; Luo J; Huang H; Du Q; Geller DA; Cheng B
Oncotarget; 2016 Feb; 7(5):5754-68. PubMed ID: 26735577
[TBL] [Abstract][Full Text] [Related]
11. Specific inhibition of Notch1 signaling suppresses properties of lung cancer stem cells.
Cai H; Lu W; Zhang Y; Liu H; Wang Z; Shen Y
J Cancer Res Ther; 2019; 15(7):1547-1552. PubMed ID: 31939436
[TBL] [Abstract][Full Text] [Related]
12. Garcinol inhibits cancer stem cell-like phenotype via suppression of the Wnt/β-catenin/STAT3 axis signalling pathway in human non-small cell lung carcinomas.
Huang WC; Kuo KT; Adebayo BO; Wang CH; Chen YJ; Jin K; Tsai TH; Yeh CT
J Nutr Biochem; 2018 Apr; 54():140-150. PubMed ID: 29414668
[TBL] [Abstract][Full Text] [Related]
13. Thymoquinone as an anticancer agent: evidence from inhibition of cancer cells viability and invasion in vitro and tumor growth in vivo.
Attoub S; Sperandio O; Raza H; Arafat K; Al-Salam S; Al Sultan MA; Al Safi M; Takahashi T; Adem A
Fundam Clin Pharmacol; 2013 Oct; 27(5):557-69. PubMed ID: 22788741
[TBL] [Abstract][Full Text] [Related]
14. Palladin promotes cancer stem cell-like properties in lung cancer by activating Wnt/Β-Catenin signaling.
Shu X; Chen M; Liu SY; Yu L; Sun LX; Sun LC; Ran YL
Cancer Med; 2023 Feb; 12(4):4510-4520. PubMed ID: 36047666
[TBL] [Abstract][Full Text] [Related]
15. [Lung Cancer Stem-like Cells and Drug Resistance].
Pan Z; Liu H; Chen J
Zhongguo Fei Ai Za Zhi; 2022 Feb; 25(2):111-117. PubMed ID: 35224964
[TBL] [Abstract][Full Text] [Related]
16. Thymoquinone-induced antitumor and apoptosis in human lung adenocarcinoma cells.
Samarghandian S; Azimi-Nezhad M; Farkhondeh T
J Cell Physiol; 2019 Jul; 234(7):10421-10431. PubMed ID: 30387147
[TBL] [Abstract][Full Text] [Related]
17. Role of YAP in lung cancer resistance to cisplatin.
Song J; Xie LX; Zhang XY; Hu P; Long MF; Xiong F; Huang J; Ye XQ
Oncol Lett; 2018 Sep; 16(3):3949-3954. PubMed ID: 30128013
[TBL] [Abstract][Full Text] [Related]
18. The effects and mechanisms of SLC34A2 on tumorigenicity in human non-small cell lung cancer stem cells.
Jiang Z; Hao Y; Ding X; Zhang Z; Liu P; Wei X; Xi J
Tumour Biol; 2016 Aug; 37(8):10383-92. PubMed ID: 26846105
[TBL] [Abstract][Full Text] [Related]
19. Thymoquinone Enhances Paclitaxel Anti-Breast Cancer Activity via Inhibiting Tumor-Associated Stem Cells Despite Apparent Mathematical Antagonism.
Bashmail HA; Alamoudi AA; Noorwali A; Hegazy GA; Ajabnoor GM; Al-Abd AM
Molecules; 2020 Jan; 25(2):. PubMed ID: 31968657
[TBL] [Abstract][Full Text] [Related]
20. Side population cells separated from A549 lung cancer cell line possess cancer stem cell-like properties and inhibition of autophagy potentiates the cytotoxic effect of cisplatin.
Yang Y; Fan Y; Qi Y; Liu D; Wu K; Wen F; Zhao S
Oncol Rep; 2015 Aug; 34(2):929-35. PubMed ID: 26081992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
